OCULAR THERAPEUTIX, INC (OCUL) has 120 open-market insider trades by 28 insiders since 2014. Over the last six months insiders net sold $928K. The most active filer is Summer ROAD LLC, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Summer ROAD LLC | 10% Owner | — | 17 | $39.0M | 2024-02-26 |
| Side Fund Iii L.p. Versant | 10% | — | 2 | $16.4M | 2015-06-15 |
| Charles M. Warden | Dir | — | 2 | $16.4M | 2026-06-10 |
| SV LIFE Sciences FUND IV Strategic Partners, L. P. | 10% | — | 1 | $16.4M | 2015-06-10 |
| Polaris Venture Partners Founders' Fund V, L.P. | 10% | — | 1 | $14.8M | 2015-02-02 |
| SVLSF Iv, LLC | 10% | — | 1 | $6.2M | 2014-07-30 |
| Pravin Dugel | — | — | 11 | $3.0M | 2026-08-25 |
| Amarpreet Sawhney | Chairman | — | 8 | $2.6M | 2019-06-07 |
| Ascension Health Ventures II, LLC | 10% | — | 1 | $2.0M | 2014-07-30 |
| Richard L. Lindstrom M.D. | Dir | — | 4 | $1.2M | 2026-06-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Todd Anderman | CLO | Sell | $87K | 2026-10-08 |
| Peter Kaiser | — | Sell | $70K | 2026-10-02 |
| Jeffrey S. Heier | CSO | Sell | $77K | 2026-10-02 |
| Donald Notman | COO | Sell | $11K | 2026-08-31 |
| Sanjay Nayak | CSO | Sell | $20K | 2026-08-24 |
| Peter Kaiser | — | Sell | $33K | 2026-08-24 |
Companies that share insiders with OCUL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jeffrey S. Heier | CSO | Sell | $36K | 2026-08-24 |
| Pravin Dugel | — | Sell | $233K | 2026-08-24 |
| Nadia Waheed | — | Sell | $123K | 2026-06-03 |
| Pravin Dugel | — | Sell | $173K | 2026-05-26 |
| Sanjay Nayak | CSO | Sell | $15K | 2026-05-26 |
| Jeffrey S. Heier | CSO | Sell | $25K | 2026-05-26 |
| Peter Kaiser | — | Sell | $24K | 2026-05-26 |
| Pravin Dugel | — | Sell | $166K | 2026-02-23 |
| Sanjay Nayak | Chief Strategy Officer | Sell | $15K | 2026-02-23 |